Key predictors of tau PET positivity across these studies included younger age, lower MMSE scores, and reduced cortical thickness in AD-related conditions, highlighting the complex interplay between systemic health, tau pathology, and AD diagnostics. The gene discussed is MAPT; the disease is Alzheimer disease.